CagriSema combines semaglutide, the active ingredient in Wegovy, with a molecule that mimics a pancreatic hormone.

Recently, there has been a lot of buzz around GLP-1 weight loss injections. Talk of Ozempic or Wegovy has been hard to miss.

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

LifeVantage (LFVN) announced the completion of an international in vitro cell study that investigated the effects of its international ...

SALT LAKE CITY - LifeVantage Corporation (NASDAQ:LFVN), a $271 million market cap player in the health and wellness sector with impressive 79% gross profit margins, today announced the successful ...

American host and television producer Oprah Winfrey recently shared her initial experience of taking the weight loss drug GLP ...

Explore how GLP-1 agonists, originally for diabetes, could transform addiction treatment by reducing cravings.

Oral semaglutide administered via the RaniPill® HC (RT-116) demonstrated comparable bioavailability, pharmacokinetics and ...

Eli Lilly expects to read out results from a study in people with obesity and osteoarthritis of the knee in 2025.

GLP-1 drugs mimic a hormone that sends the brain signals of fullness. Researchers theorize that the drugs could work the same ...

As “GLP-1 receptor agonists,” they mimic a naturally occurring hormone, GLP-1, released in the body after someone eats. For reasons that remain unclear, many patients that struggle with ...